von Delius, Stefan <br/><br/>
Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma.  [electronic resource] 

 -  BMC cancer  Jun 2005 
 - 61 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/1471-2407-5-61  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--metabolism<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Biliary Tract Neoplasms--drug therapy<br/>Carcinoma--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Disease Progression<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Female<br/>Gallbladder Neoplasms--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Models, Statistical<br/>Time Factors<br/>Tomography, X-Ray Computed<br/>Treatment Outcome<br/>Gemcitabine